معرفی
Keith Al-Hasani is an Adjunct Senior Research Fellow at Monash University, specializing in diabetes research with a focus on pancreatic regeneration and epigenetic mechanisms. His work contributes to UN Sustainable Development Goals related to health and well-being.
Past Affiliations:
- Vaccine Scientist (Manager), Therapeutic Goods Administration (2016–2017)
- Research Fellow, INSERM (2009–2012)
- Research Fellow, Murdoch Children's Research Institute (2001–2004)
Research Interests: His research explores epigenetic regulation in β-cell regeneration, diabetic nephropathy biomarkers, and therapeutic targets for diabetes. Key projects include the PanRegen and EpiPR initiatives, investigating pancreatic ductal cell-driven β-cell regeneration and epigenetic modulation.
Recent Trends in Publications: Over the past five years, his work emphasizes epigenetic therapies for diabetes complications, pharmacological interventions targeting EZH2, and biomarker discovery for kidney disease susceptibility. Collaborations span Australia, Europe, and Asia.
Grants & Projects:
- Primary Chief Investigator for PanRegen: Pancreas Regeneration Project (2021–2022)
- Chief Investigator for Epigenetic Pancreas Regeneration (EpiPR) Project (2022)
Labs/Teams: Collaborates closely with labs led by S. El-Osta and M. Cooper, focusing on translational research in diabetes and epigenetics.
